Poïesis Populates Pipeline with Investment the Missing Link

Poïesis Populates Pipeline with Investment the Missing Link

By Joseph Harvey, Editor, March 15, 2018 US companion animal medicines firm Poïesis Therapeutics is now working on in-licensing a pipeline of eight candidates from human biotechnology companies. The San Diego-based business is looking to develop a range of potential...
Poïesis Opens Seed Round Seeking $5 Million

Poïesis Opens Seed Round Seeking $5 Million

Following on its move from London to San Diego, California, Poïesis has opened its Seed Round of financing seeking to raise $5 million to complete in-licensing and initiate clinical development of its therapeutic and diagnostic pipeline in several indications in dogs,...